Annual ROE
-99.97%
-49.11%-96.56%
December 31, 2023
Summary
- As of February 7, 2025, SCPH annual return on equity is -99.97%, with the most recent change of -49.11% (-96.56%) on December 31, 2023.
- During the last 3 years, SCPH annual ROE has fallen by -60.77% (-155.03%).
- SCPH annual ROE is now -252.05% below its all-time high of 65.75%, reached on December 31, 2016.
Performance
SCPH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-265.48%
-100.33%-60.75%
September 30, 2024
Summary
- As of February 7, 2025, SCPH quarterly return on equity is -265.48%, with the most recent change of -100.33% (-60.75%) on September 30, 2024.
- Over the past year, SCPH quarterly ROE has dropped by -173.53% (-188.72%).
- SCPH quarterly ROE is now -203.90% below its all-time high of 255.51%, reached on September 30, 2017.
Performance
SCPH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SCPH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -96.6% | -188.7% |
| 3 y3 years | -155.0% | -248.4% |
| 5 y5 years | -167.4% | -248.4% |
SCPH ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -101.4% | at low | -525.4% | at low |
| 5 y | 5-year | -155.0% | at low | -611.9% | at low |
| alltime | all time | -252.1% | at low | -203.9% | at low |
ScPharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -265.48%(+60.8%) |
| Jun 2024 | - | -165.15%(+43.2%) |
| Mar 2024 | - | -115.34%(+25.4%) |
| Dec 2023 | -99.97%(+96.6%) | -91.95%(+19.3%) |
| Sep 2023 | - | -77.06%(+4.5%) |
| Jun 2023 | - | -73.77%(+0.5%) |
| Mar 2023 | - | -73.37%(-3.7%) |
| Dec 2022 | -50.86%(+2.5%) | -76.19%(-3.2%) |
| Sep 2022 | - | -78.70%(+31.6%) |
| Jun 2022 | - | -59.78%(+24.1%) |
| Mar 2022 | - | -48.17%(+13.5%) |
| Dec 2021 | -49.64%(+26.6%) | -42.45%(+7.9%) |
| Sep 2021 | - | -39.33%(+0.4%) |
| Jun 2021 | - | -39.16%(+5.0%) |
| Mar 2021 | - | -37.29%(-5.9%) |
| Dec 2020 | -39.20% | -39.62%(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -47.89%(-3.1%) |
| Jun 2020 | - | -49.40%(-10.3%) |
| Mar 2020 | - | -55.07%(+1.4%) |
| Dec 2019 | -64.24%(+71.8%) | -54.29%(+34.6%) |
| Sep 2019 | - | -40.34%(+11.3%) |
| Jun 2019 | - | -36.26%(-1.1%) |
| Mar 2019 | - | -36.66%(+8.5%) |
| Dec 2018 | -37.39%(+66.4%) | -33.78%(+1.7%) |
| Sep 2018 | - | -33.22%(-16.2%) |
| Jun 2018 | - | -39.66%(+7.0%) |
| Mar 2018 | - | -37.08%(-2.2%) |
| Dec 2017 | -22.47%(-134.2%) | -37.91%(-114.8%) |
| Sep 2017 | - | 255.51%(+465.0%) |
| Jun 2017 | - | 45.22%(+63.9%) |
| Mar 2017 | - | 27.59%(+92.4%) |
| Dec 2016 | 65.75%(+14.0%) | 14.34% |
| Dec 2015 | 57.66% | - |
FAQ
- What is scPharmaceuticals annual return on equity?
- What is the all time high annual ROE for scPharmaceuticals?
- What is scPharmaceuticals annual ROE year-on-year change?
- What is scPharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for scPharmaceuticals?
- What is scPharmaceuticals quarterly ROE year-on-year change?
What is scPharmaceuticals annual return on equity?
The current annual ROE of SCPH is -99.97%
What is the all time high annual ROE for scPharmaceuticals?
scPharmaceuticals all-time high annual return on equity is 65.75%
What is scPharmaceuticals annual ROE year-on-year change?
Over the past year, SCPH annual return on equity has changed by -49.11% (-96.56%)
What is scPharmaceuticals quarterly return on equity?
The current quarterly ROE of SCPH is -265.48%
What is the all time high quarterly ROE for scPharmaceuticals?
scPharmaceuticals all-time high quarterly return on equity is 255.51%
What is scPharmaceuticals quarterly ROE year-on-year change?
Over the past year, SCPH quarterly return on equity has changed by -173.53% (-188.72%)